194
Participants
Start Date
June 6, 2018
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2025
Biomarker strategy
EAT duration is determined by β-D-1,3-glucan and mannan serum assays, performed at day 0 (day of EAT initiation) and day 3.
Routine strategy
EAT duration is based on IDSA guidelines, which recommend 14 days of treatment for patients without subsequent proven ICI, and who improve under antifungal treatment, or less in other situations.
RECRUITING
CH ARRAS, Arras
RECRUITING
CH de DOUAI, Douai
RECRUITING
CH Dunkerque, Dunkirk
RECRUITING
Centre Hospitalier Dr Schaffner, Lens
RECRUITING
Ch Dr.Schaffner de Lens, Lens
RECRUITING
Hôpital Roger Salengro, CHU, Lille
RECRUITING
CH Roubaix, Roubaix
RECRUITING
CHU de Rouen, Rouen
RECRUITING
Ch Tourcoing, Tourcoing
RECRUITING
Centre hospitalier de valenciennes, Valenciennes
University Hospital, Lille
OTHER